about
Nanotechnology-based drug delivery systems for the treatment of Alzheimer's diseaseNonionic surfactant vesicles in ocular delivery: innovative approaches and perspectivesPolycarboxylic acid nanoparticles for ophthalmic drug delivery: an ex vivo evaluation with human cornea.NC-1059: a channel-forming peptide that modulates drug delivery across in vitro corneal epitheliumSynthesis and evaluation of a nanoglobular dendrimer 5-aminosalicylic Acid conjugate with a hydrolyzable schiff base spacer for treating retinal degeneration.Solid lipid nanoparticles for ocular drug delivery.Niosome-encapsulated gentamicin for ophthalmic controlled delivery.Targeted delivery of antiglaucoma drugs to the supraciliary space using microneedles.Enhanced cytotoxicity for colon 26 cells using doxorubicin-loaded sorbitan monooleate (Span 80) vesiclesMultifunctional PEG retinylamine conjugate provides prolonged protection against retinal degeneration in mice.Recent applications of liposomes in ophthalmic drug delivery.Development of dorzolamide loaded 6-o-carboxymethyl chitosan nanoparticles for open angle glaucomaRecent patents on ophthalmic nanoformulations and therapeutic implicationsNanovesicular formulation of brimonidine tartrate for the management of glaucoma: in vitro and in vivo evaluationCationic vectors in ocular drug delivery.Eye drop delivery of pigment epithelium-derived factor-34 promotes retinal ganglion cell neuroprotection and axon regeneration.Preformulation Studies of a Liposomal Formulation Containing Sirolimus for the Treatment of Dry Eye Disease.Ocular drug delivery: nanomedicine applications.Approaches for enhancing oral bioavailability of peptides and proteinsRecent perspectives in ocular drug delivery.Drug delivery systems for the eye.Niosomes in sustained and targeted drug delivery: some recent advances.Feasibility of lipid nanoparticles for ocular delivery of anti-inflammatory drugs.Redefining tissue engineering for nanomedicine in ophthalmology.Ocular drug delivery - a look towards nanobioadhesives.Tissue bioanalysis of biotherapeutics and drug targets to support PK/PD.Eradication of superficial fungal infections by conventional and novel approaches: a comprehensive review.Nanotechnology approaches for ocular drug delivery.Impacts of nanomedicines in ocular pharmacotherapyBenefits of cetalkonium chloride cationic oil-in-water nanoemulsions for topical ophthalmic drug delivery.Recent advances in non-ionic surfactant vesicles (niosomes): self-assembly, fabrication, characterization, drug delivery applications and limitations.Topical delivery of ocular therapeutics: carrier systems and physical methods.Colloidal drug delivery system: amplify the ocular delivery.Current strategies for DNA therapy based on lipid nanocarriers.Ocular drug delivery systems: An overview.Cubosomes and other potential ocular drug delivery vehicles for macromolecular therapeutics.Ocular delivery systems for topical application of anti-infective agents.Advance of the application of nano-controlled release system in ophthalmic drug delivery.Nanoparticles as tool for enhanced ophthalmic delivery of vancomycin: a multidistrict-based microbiological study, solid lipid nanoparticles formulation and evaluation.Extended ocular drug delivery systems for the anterior and posterior segments: biomaterial options and applications.
P2860
Q26783306-1CDE8517-4F31-4DD3-9C32-19BCFE29A1C3Q26999057-79417585-BA8D-40F5-8309-FFFB2D652CA4Q30780975-DFF2118C-5D3B-4FBB-8B53-08CEE7632354Q33582539-D972080F-8564-44EB-91AF-CD4453C19F3CQ33768680-00463BC3-2ACA-405D-8C93-F4632A23ADE5Q34116807-BE7D0A5F-EBC2-4282-8D90-8D32B3EB4A10Q34293775-62B77CDB-C27F-42C8-AEC7-A1CC376C8C07Q34511234-31A05A7B-79A7-448D-B95F-F317C29B37E5Q34587836-5D2B4859-02A1-4F00-A542-553840E63BB6Q34669685-BD028BFA-8DB1-41F9-81FB-FA482923ADECQ34734683-4F2CB980-4D58-4FC9-AE77-50403652CDB3Q35040009-DE7326B4-7162-45D0-BD7D-DE8AB35A1B8BQ35043004-238B3584-2C2C-475D-A080-F1274A984A9AQ35100349-5F6F1931-2C34-4434-A0AD-717F798666A3Q35994783-18075628-A1C7-408A-90C7-F1E74359F7E8Q36159673-D3D1A61A-5C94-4181-A6A2-816B161A7309Q36549331-7BB6626C-29D8-403F-BB99-3EB39F1E93D3Q36918036-7E6CD2BC-D028-491D-B022-21EBE374536BQ36922557-876D1DF7-11CD-459C-A16D-85D52B5FB9B3Q37256549-AFB905AC-E6DB-44F3-99A3-78B242F10797Q37472106-4349485F-C789-4057-BB3A-FC1B6DF991D3Q37618808-F6270E12-1EBE-4B02-A1C8-078A640DBE0FQ37769529-99F5FDA4-8A9D-471C-A846-F1D2558919CEQ37782373-E223529C-F2FD-4158-B241-E756409144EFQ37822756-35F7AFD4-8347-4894-8F30-3A04C5BF37AAQ38061684-192A773F-2D95-4121-B508-8F8C43A92D8CQ38085729-2C80511F-C74B-48FD-B557-ECE4A98D6505Q38098509-E7D11241-9AB7-406A-AAD4-B34F5FCA0E8CQ38107200-F57B34CA-F06D-4C24-A6E6-F4C8330FCEFEQ38133883-549588EC-4A8D-4224-A83D-8C92749781B2Q38155210-3ED33535-6AA7-417D-9128-E45FAD955F43Q38196446-300F62EF-6E19-4CD4-887D-90806A4128B3Q38217270-53E91BD9-FA0A-4A30-9173-B470C1E5DA17Q38232143-1C413D50-9E08-47FF-B468-3FB5E2F58426Q38318837-3711A6F1-13DB-4682-9268-6B9A7E5C2541Q38368715-E7D7A896-74F5-4F04-AEA3-28B693A8BACAQ38577846-B3580633-7D7D-4D62-A38E-599C059E7475Q38658684-166C1C05-1997-4893-8FE4-93EDE8074100Q38878972-71D6CC39-A77A-445C-82FE-E77790A4F86AQ38934604-8853FD7E-8F3A-4870-BAE5-92DF0E09C77B
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Vesicular systems in ocular drug delivery: an overview.
@ast
Vesicular systems in ocular drug delivery: an overview.
@en
type
label
Vesicular systems in ocular drug delivery: an overview.
@ast
Vesicular systems in ocular drug delivery: an overview.
@en
prefLabel
Vesicular systems in ocular drug delivery: an overview.
@ast
Vesicular systems in ocular drug delivery: an overview.
@en
P2093
P1476
Vesicular systems in ocular drug delivery: an overview.
@en
P2093
Anil K Singla
Deepika Aggarwal
Indu P Kaur
P356
10.1016/J.IJPHARM.2003.09.016
P407
P577
2004-01-01T00:00:00Z